Paper8553567
Isolation of cytotoxic T lymphocytes from healthy seropositive individuals specific for peptide epitopes from Epstein-Barr virus nuclear antigen 1: implications for viral persistence and tumor surveillance.
Khanna R and 5 others. Virology, 1995. Cited by 69 papers, by iCite.
Cite this record
ConductScience Library. Isolation of cytotoxic T lymphocytes from healthy seropositive individuals specific for peptide epitopes from Epstein-Barr virus nuclear antigen 1: implications for viral persistence and tumor surveillance. Papers, record 8553567. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8553567
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Isolation of cytotoxic T lymphocytes from healthy seropositive individuals specific for peptide epitopes from Epstein-Barr virus nuclear antigen 1: implications for viral persistence and tumor surveillance.
- PubMed
- Publication types
- Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antigens, Viral | Major topic |
| DNA-Binding Proteins | Major topic |
| Herpesviridae Infections | Major topic |
| Herpesvirus 4, Human | Major topic |
| Immunologic Surveillance | Major topic |
| T-Lymphocytes, Cytotoxic | Major topic |
| Tumor Virus Infections | Major topic |
| Amino Acid Sequence | |
| Cell Line, Transformed | |
| Cells, Cultured | |
| Epitopes | |
| Epstein-Barr Virus Nuclear Antigens | |
| Humans | |
| Molecular Sequence Data | |
| Peptides | |
| Virus Latency |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| CA-52250-04 | NCI NIH HHS | United States | PubMed | PubMed | |
| R01CA052250 | NIH | NIH RePORTER |
Cited by29
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 69 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37553346 | Lymph node targeted multi-epitope subunit vaccine promotes effective immunity to EBV in HLA-expressing mice. | Nat Commun | 2023 | https://conductscience.org/library/papers/37553346 | PubMed |
| 34115118 | CMV exposure drives long-term CD57+ CD4 memory T-cell inflation following allogeneic stem cell transplant. | Blood | 2021 | https://conductscience.org/library/papers/34115118 | PubMed |
| 24981123 | Porcine reproductive and respiratory syndrome (PRRS): an immune dysregulatory pandemic. | Immunol Res | 2014 | https://conductscience.org/library/papers/24981123 | PubMed |
| 23569328 | MHC II tetramers visualize human CD4+ T cell responses to Epstein-Barr virus infection and demonstrate atypical kinetics of the nuclear antigen EBNA1 response. | J Exp Med | 2013 | https://conductscience.org/library/papers/23569328 | PubMed |
| 22002875 | A clonal model for human CD8+ regulatory T cells: unrestricted contact-dependent killing of activated CD4+ T cells. | Eur J Immunol | 2012 | https://conductscience.org/library/papers/22002875 | PubMed |
| 21622860 | Cytotoxic CD4+ T cell responses to EBV contrast with CD8 responses in breadth of lytic cycle antigen choice and in lytic cycle recognition. | J Immunol | 2011 | https://conductscience.org/library/papers/21622860 | PubMed |
| 20133861 | Nuclear location of an endogenously expressed antigen, EBNA1, restricts access to macroautophagy and the range of CD4 epitope display. | Proc Natl Acad Sci U S A | 2010 | https://conductscience.org/library/papers/20133861 | PubMed |
| 18754877 | Epstein-Barr virus nuclear antigen 1-specific CD4+ T cells directly kill Epstein-Barr virus-carrying natural killer and T cells. | Cancer Sci | 2008 | https://conductscience.org/library/papers/18754877 | PubMed |
| 17942757 | Repertoire and frequency of immune cells reactive to Epstein-Barr virus-derived autologous lymphoblastoid cell lines. | Blood | 2008 | https://conductscience.org/library/papers/17942757 | PubMed |
| 17937498 | Human CD4+ T cell epitopes from vaccinia virus induced by vaccination or infection. | PLoS Pathog | 2007 | https://conductscience.org/library/papers/17937498 | PubMed |
| 17611619 | Immunodominance of lytic cycle antigens in Epstein-Barr virus-specific CD4+ T cell preparations for therapy. | PLoS One | 2007 | https://conductscience.org/library/papers/17611619 | PubMed |
| 16542378 | Selection of Epstein-Barr virus specific cytotoxic T lymphocytes can be performed with B lymphoblastoid cell lines created in serum-free media. | Clin Exp Immunol | 2006 | https://conductscience.org/library/papers/16542378 | PubMed |
| 16456552 | Characterization of an immuno 'stealth' derivative of the herpes simplex virus thymidine-kinase gene. | Cancer Gene Ther | 2006 | https://conductscience.org/library/papers/16456552 | PubMed |
| 15827162 | Regression of Epstein-Barr virus-induced B-cell transformation in vitro involves virus-specific CD8+ T cells as the principal effectors and a novel CD4+ T-cell reactivity. | J Virol | 2005 | https://conductscience.org/library/papers/15827162 | PubMed |
| 15795275 | CD4+ T-cell responses to Epstein-Barr virus (EBV) latent-cycle antigens and the recognition of EBV-transformed lymphoblastoid cell lines. | J Virol | 2005 | https://conductscience.org/library/papers/15795275 | PubMed |
| 15314691 | Critical role of EBNA1-specific CD4+ T cells in the control of mouse Burkitt lymphoma in vivo. | J Clin Invest | 2004 | https://conductscience.org/library/papers/15314691 | PubMed |
| 14769850 | Evidence for the presentation of major histocompatibility complex class I-restricted Epstein-Barr virus nuclear antigen 1 peptides to CD8+ T lymphocytes. | J Exp Med | 2004 | https://conductscience.org/library/papers/14769850 | PubMed |
| 14581546 | Cytolytic CD4(+)-T-cell clones reactive to EBNA1 inhibit Epstein-Barr virus-induced B-cell proliferation. | J Virol | 2003 | https://conductscience.org/library/papers/14581546 | PubMed |
| 14566361 | Creation of immune 'stealth' genes for gene therapy through fusion with the Gly-Ala repeat of EBNA-1. | Gene Ther | 2003 | https://conductscience.org/library/papers/14566361 | PubMed |
| 12828556 | Retroviral transfer of T-cell receptor genes produces cells with a broad range of lytic activity. | Scand J Immunol | 2003 | https://conductscience.org/library/papers/12828556 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8553567
GET https://conductscience.org/api/papers/v1/8553567/cited_by?page=2